Alcohol Treatment Center

It is an unfortunate fact that the majority of people who experience substance abuse problems for a variety of reasons never receive the assistance that they so desperately need. There is a growing body of evidence which proves that individuals exposed to particular types of treatment in Alcohol Treatment Centers experience the result that their use of psychoactive substances is subsequently reduced and improvement in the other various areas of the person's life show a significant amelioration as well.

It is a safe statement to make that treatment in Alcohol Treatment Centers outcomes are improved when a series of coherent and complete relevant treatment in Alcohol Treatment Centers are provided to assist the individual in coping with their significant life problems, such as problems with interpersonal communications, unemployment, and lack of self esteem.

An extensive body of medical clinical research has been conducted on the specific subject of administering treatment in Alcohol Treatment Centers for individuals with alcohol and other drug problems. It must be considered whenever examining the results of such clinical research that the majority of the studies considered have not utilized a strategy of complete abstinence as the only or even main measurement of success. Instead, they have utilized several continuous outcome measures such as percentage of alcohol drink days, amount consumed per alcohol drink occasion and other similar factors.

This aspect of the research points out a perspective of substance abuse as a chronic condition which is subject to relapse, and for which the various goals of either amelioration or outright termination of the condition may be appropriate. Similarly to the way that many other chronic conditions are approached, such as obesity, asthma, or diabetes, the expectation that substance abuse will be completely and/or permanently eliminated following a single intervention of treatment in Alcohol Treatment Centers is to be considered wholly unrealistic. It should also be considered that considerable improvements may follow medical and psychological interventions, and that these results can be quantified and reported clearly.

When considering pharmacotherapies, four separate drug classes are categorized:

- Psychotropic drugs.
- Antidipsotropic drugs.
- Anti-craving drugs.

Psychotropic Drug Therapy

Psychotropic drugs are a type of medication which is implemented to improve the individual's psychological status based on the expectation that this will strategy will result in reduced consumption of alcohol. This type of medication includes anti-psychotic drugs, anti-anxiety drugs, anti-depressant drugs, and psychedelics as well as lithium. Research has shown that there is a substantial amount of evidence to conclude that the use of antidepressants can lead to positive results in the course of treatment in Alcohol Treatment Centers of alcohol-related problems. In the case of lithium the evidence is still indeterminate; in the case of antipsychotic medication it is too restricted to merit definitive conclusions; and in the case of psychedelics and antianxiety drugs the clinical evidence is quite firmly not supportive of their implementation.

Antidipsotropic Drug Therapy

Antidipsotropic drugs are a type of medication which is known to provoke an unpleasant reaction when used with alcohol. Implants of disulfiram are considered to have a reasonable amount of clinical evidence to vouch for their effectiveness. Some researchers place this therapy on a more or less equivalent effectiveness index with social skills training and marital behavioral therapy. Disulfiram therapy can be a very effective addition to a coherent treatment in Alcohol Treatment Centers program that includes methods to assist individuals in the process of adhesion to the longer term regimen of regularly scheduled doses of disulfiram, as well as increasing the motivation for compliance and to encourage the prevention of future relapses.

It is always problematical to be able to compare various research studies which are attempting to determine statistical factual data based on differences in methods and subjects. There have been research studies where the individuals were coerced into treatment in Alcohol Treatment Centers with oral disulfiram. Oral disulfiram seems to have an edge over the implanted disulfiram when administered in a coherent strategy specifically with individuals involved in comprehensive programs. The clinical evidence points to the finding that socially stable clients are likely to gain greater benefit from disulfiram than others. Research points to the discovery that patients who were already highly motivated and compliant with the treatment in Alcohol Treatment Centers process also benefit more from the drugs administered as part of their therapy than others.

Clinical research into the various antidipsotropic medications which were in common use years ago has shown that these particular older drugs are not particularly effective. The evidence for the use of calcium carbimide and metronidazole showed that the effects were so slight as to evade definitive conclusions.

Anti-craving Drug Therapy

Medications which are frequently utilized for this specific purpose are zimelidine, fluoxetine, and citalopram. Extensive and medically accurate clinical trials using these drugs with non-depressed, mildly to moderately dependent individuals have shown that they can be responsible for decreased short-term alcohol intake by approximately 20%.

There are other drugs such as 5-HT antagonist ritansarin and 5-HT agonist buspirone which may reduce craving, however, these conclusions are plagued by the inconsistent results of the current controlled trials which have found no difference in outcomes in either depressed or non-depressed individuals when statistically calculated against a control group utilizing only placebos.

Naltrexone is yet another medication that has been used in recent studies analyzing the situation of social and heavy drinkers receiving treatment. Naltrexone is an opiate antagonist which has the beneficial effect in the individual patient to reduce craving for alcohol. A number of clinical trials and various medical studies with alcohol-dependent subjects, it was shown that those individuals who were receiving naltrexone consumed alcohol on fewer occasions and experienced a lower percentage of relapse to heavy alcohol consumption than those individuals in the clinical trial who were administered only a placebo. Naltrexone is approved for utilization in alcohol treatment in Alcohol Treatment Centers in North America and acceptance of this medication is growing in clinical institutions around the world. Naltrexone has now been recognized as a valid component of a coherent strategy of treatment.